{"id": "1356639982295867397", "creation": 1612283151.0, "user_id": "1230877109670772737", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 13, "reply_count": 0, "like_count": 12, "quote_count": 0}}, "quoted": "1356580678201204736", "text": "Good news! One more #vaccine w/ high efficacy against #SARSCoV2 .\nStudy @TheLancet w/ 20k participants - phase 3 trial showing 91,6% x symptomatic #COVID19. \n@areinamo21 @PIPSQC @DeannaMarie208 @ArditiMd @rjabornisky @sgdambrauskas @yoncabulutmd @JennaMillerKC \n\n#covid4MDs #MedEd https://t.co/FF6zgv4UcO https://t.co/spgII4kuAi", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#SARSCOV2", "#COVID19", "#COVID4MDS", "#MEDED"]}